Celldex Therapeutics buy Morgan Stanley
Start price
20.03.25
/
50%
€18.40
Target price
20.03.26
€42.18
Performance (%)
42.39%
End price
21.03.26
€26.20
Summary
This prediction ended on 21.03.26 with a price of €26.20. With a performance of 42.39% the BUY prediction by Morgan_Stanley was a big success. Morgan_Stanley has a follow-up prediction for Celldex Therapeutics where he still thinks Celldex Therapeutics is a Buy. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Celldex Therapeutics | -8.863% | -8.863% | 59.895% |
| iShares Core DAX® | 0,07 % | 0,24 % | 2,89 % |
| iShares Nasdaq 100 | -1,34 % | -3,37 % | 29,21 % |
| iShares Nikkei 225® | -2,31 % | -7,50 % | 56,32 % |
| iShares S&P 500 | -0,34 % | 0,90 % | 23,17 % |
Comments by Morgan_Stanley for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics, Inc. (NASDAQ: CLDX) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $46.00 price target on the stock.
Ratings data for CLDX provided by MarketBeat
In the thread Trading Celldex Therapeutics
Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten
Current prediction by Morgan_Stanley for Celldex Therapeutics
Stopped prediction by Morgan_Stanley for Celldex Therapeutics
Celldex Therapeutics
Start price
Target price
Perf. (%)
€16.30
09.05.25
09.05.25
€38.34
09.05.26
09.05.26
74.29%
10.05.26
10.05.26
